Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02506517
Title A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

Advanced Solid Tumor

Therapies

Afatinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.